These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 33124145)

  • 1. Prediction of the development of islet autoantibodies through integration of environmental, genetic, and metabolic markers.
    Webb-Robertson BM; Bramer LM; Stanfill BA; Reehl SM; Nakayasu ES; Metz TO; Frohnert BI; Norris JM; Johnson RK; Rich SS; Rewers MJ
    J Diabetes; 2021 Feb; 13(2):143-153. PubMed ID: 33124145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progression from islet autoimmunity to clinical type 1 diabetes is influenced by genetic factors: results from the prospective TEDDY study.
    Beyerlein A; Bonifacio E; Vehik K; Hippich M; Winkler C; Frohnert BI; Steck AK; Hagopian WA; Krischer JP; Lernmark Å; Rewers MJ; She JX; Toppari J; Akolkar B; Rich SS; Ziegler AG;
    J Med Genet; 2019 Sep; 56(9):602-605. PubMed ID: 30287597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Early Exposure of Probiotics and Islet Autoimmunity in the TEDDY Study.
    Uusitalo U; Liu X; Yang J; Aronsson CA; Hummel S; Butterworth M; Lernmark Å; Rewers M; Hagopian W; She JX; Simell O; Toppari J; Ziegler AG; Akolkar B; Krischer J; Norris JM; Virtanen SM;
    JAMA Pediatr; 2016 Jan; 170(1):20-8. PubMed ID: 26552054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Type 1 Diabetes Genetic Risk Score Predicts Progression of Islet Autoimmunity and Development of Type 1 Diabetes in Individuals at Risk.
    Redondo MJ; Geyer S; Steck AK; Sharp S; Wentworth JM; Weedon MN; Antinozzi P; Sosenko J; Atkinson M; Pugliese A; Oram RA;
    Diabetes Care; 2018 Sep; 41(9):1887-1894. PubMed ID: 30002199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The environment and the origins of islet autoimmunity and Type 1 diabetes.
    Eringsmark Regnéll S; Lernmark A
    Diabet Med; 2013 Feb; 30(2):155-60. PubMed ID: 23252770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting Islet Cell Autoimmunity and Type 1 Diabetes: An 8-Year TEDDY Study Progress Report.
    Krischer JP; Liu X; Vehik K; Akolkar B; Hagopian WA; Rewers MJ; She JX; Toppari J; Ziegler AG; Lernmark Å;
    Diabetes Care; 2019 Jun; 42(6):1051-1060. PubMed ID: 30967432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accelerated progression from islet autoimmunity to diabetes is causing the escalating incidence of type 1 diabetes in young children.
    Ziegler AG; Pflueger M; Winkler C; Achenbach P; Akolkar B; Krischer JP; Bonifacio E
    J Autoimmun; 2011 Aug; 37(1):3-7. PubMed ID: 21376535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic scores to stratify risk of developing multiple islet autoantibodies and type 1 diabetes: A prospective study in children.
    Bonifacio E; Beyerlein A; Hippich M; Winkler C; Vehik K; Weedon MN; Laimighofer M; Hattersley AT; Krumsiek J; Frohnert BI; Steck AK; Hagopian WA; Krischer JP; Lernmark Å; Rewers MJ; She JX; Toppari J; Akolkar B; Oram RA; Rich SS; Ziegler AG;
    PLoS Med; 2018 Apr; 15(4):e1002548. PubMed ID: 29614081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integration of Infant Metabolite, Genetic, and Islet Autoimmunity Signatures to Predict Type 1 Diabetes by Age 6 Years.
    Webb-Robertson BM; Nakayasu ES; Frohnert BI; Bramer LM; Akers SM; Norris JM; Vehik K; Ziegler AG; Metz TO; Rich SS; Rewers MJ
    J Clin Endocrinol Metab; 2022 Jul; 107(8):2329-2338. PubMed ID: 35468213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting progression to type 1 diabetes from ages 3 to 6 in islet autoantibody positive TEDDY children.
    Jacobsen LM; Larsson HE; Tamura RN; Vehik K; Clasen J; Sosenko J; Hagopian WA; She JX; Steck AK; Rewers M; Simell O; Toppari J; Veijola R; Ziegler AG; Krischer JP; Akolkar B; Haller MJ;
    Pediatr Diabetes; 2019 May; 20(3):263-270. PubMed ID: 30628751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of non-HLA genes associated with development of islet autoimmunity and type 1 diabetes in the prospective TEDDY cohort.
    Sharma A; Liu X; Hadley D; Hagopian W; Chen WM; Onengut-Gumuscu S; Törn C; Steck AK; Frohnert BI; Rewers M; Ziegler AG; Lernmark Å; Toppari J; Krischer JP; Akolkar B; Rich SS; She JX;
    J Autoimmun; 2018 May; 89():90-100. PubMed ID: 29310926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An interferon-induced helicase (IFIH1) gene polymorphism associates with different rates of progression from autoimmunity to type 1 diabetes.
    Winkler C; Lauber C; Adler K; Grallert H; Illig T; Ziegler AG; Bonifacio E
    Diabetes; 2011 Feb; 60(2):685-90. PubMed ID: 21270278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamics of Islet Autoantibodies During Prospective Follow-Up From Birth to Age 15 Years.
    Pöllänen PM; Ryhänen SJ; Toppari J; Ilonen J; Vähäsalo P; Veijola R; Siljander H; Knip M
    J Clin Endocrinol Metab; 2020 Dec; 105(12):e4638-51. PubMed ID: 32882033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Class II HLA Genotype Association With First-Phase Insulin Response Is Explained by Islet Autoantibodies.
    Koskinen MK; Lempainen J; Löyttyniemi E; Helminen O; Hekkala A; Härkönen T; Kiviniemi M; Simell O; Knip M; Ilonen J; Toppari J; Veijola R
    J Clin Endocrinol Metab; 2018 Aug; 103(8):2870-2878. PubMed ID: 29300921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Respiratory infections are temporally associated with initiation of type 1 diabetes autoimmunity: the TEDDY study.
    Lönnrot M; Lynch KF; Elding Larsson H; Lernmark Å; Rewers MJ; Törn C; Burkhardt BR; Briese T; Hagopian WA; She JX; Simell OG; Toppari J; Ziegler AG; Akolkar B; Krischer JP; Hyöty H;
    Diabetologia; 2017 Oct; 60(10):1931-1940. PubMed ID: 28770319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age- and islet autoimmunity-associated differences in amino acid and lipid metabolites in children at risk for type 1 diabetes.
    Pflueger M; Seppänen-Laakso T; Suortti T; Hyötyläinen T; Achenbach P; Bonifacio E; Orešič M; Ziegler AG
    Diabetes; 2011 Nov; 60(11):2740-7. PubMed ID: 22025777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late-onset islet autoimmunity in childhood: the Diabetes Autoimmunity Study in the Young (DAISY).
    Frohnert BI; Ide L; Dong F; Barón AE; Steck AK; Norris JM; Rewers MJ
    Diabetologia; 2017 Jun; 60(6):998-1006. PubMed ID: 28314946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infant Feeding in Relation to the Risk of Advanced Islet Autoimmunity and Type 1 Diabetes in Children With Increased Genetic Susceptibility: A Cohort Study.
    Hakola L; Takkinen HM; Niinistö S; Ahonen S; Nevalainen J; Veijola R; Ilonen J; Toppari J; Knip M; Virtanen SM
    Am J Epidemiol; 2018 Jan; 187(1):34-44. PubMed ID: 29309515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infant feeding in relation to islet autoimmunity and type 1 diabetes in genetically susceptible children: the MIDIA Study.
    Lund-Blix NA; Stene LC; Rasmussen T; Torjesen PA; Andersen LF; Rønningen KS
    Diabetes Care; 2015 Feb; 38(2):257-63. PubMed ID: 25422170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Type 1 Diabetes-Associated SNPs on Risk of Autoantibody Positivity in the TEDDY Study.
    Törn C; Hadley D; Lee HS; Hagopian W; Lernmark Å; Simell O; Rewers M; Ziegler A; Schatz D; Akolkar B; Onengut-Gumuscu S; Chen WM; Toppari J; Mykkänen J; Ilonen J; Rich SS; She JX; Steck AK; Krischer J;
    Diabetes; 2015 May; 64(5):1818-29. PubMed ID: 25422107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.